Abstract
Diacylglycerols (DAG) have been shown to have beneficial effects on obesity and weight-related disorders. The reduction on the body fat accumulation shown by DAG in both animal and human studies is believed to be attributed to its metabolic pathway, which is different from triacylglycerol (TAG) metabolism. In this chapter, we highlight the differences in the physicochemical properties and the metabolic pathway between DAG and TAG. Various patented processes for the production of DAG oil from different reaction routes are discussed. A review of patent literature of the commercial products based on DAG fats and oils and the regulatory and safety aspects of these products is also provided.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
